Allogeneic Human Umbilical Cord Wharton's Jelly Stem Cells Increase Several-fold the Expansion of Human Cord Blood CD34+ Cells Both in Vitro and in Vivo

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2020 Dec 10

PMID 33298170

Citations 5

Authors

Hao Daniel Lin

Chui-Yee Fong

Arijit Biswas

Ariff Bongso

Affiliations

Soon will be listed here.

Abstract

Background: The transplantation of human umbilical cord blood (UCB) CD34+ cells has been successfully used to treat hematological disorders but one major limitation has been the low cell numbers available. Mesenchymal stem cells (MSCs) lying within the bone marrow in vivo behave like a scaffold on which CD34+ cells interact and proliferate. We therefore evaluated the use of allogeneic MSCs from the human UC Wharton's jelly (hWJSCs) as stromal support for the ex vivo expansion of CD34+ cells.

Methods: We performed an in-depth evaluation of the primitiveness, migration, adhesion, maturation, mitochondrial behavior, and pathway mechanisms of this platform using conventional assays followed by the evaluation of engraftment potential of the expanded CD34+ cells in an in vivo murine model.

Results: We demonstrate that hWJSCs and its conditioned medium (hWJSC-CM) support the production of significantly high fold changes of CD34+, CD34+CD133+, CD34+CD90+, CD34+ALDH+, CD34+CD45+, and CD34+CD49f+ cells after 7 days of interaction when compared to controls. In the presence of hWJSCs or hWJSC-CM, the CD34+ cells produced significantly more primitive CFU-GEMM colonies, HoxB4, and HoxA9 gene expression and lower percentages of CD34+CXCR4+ cells. There were also significantly higher N-cadherin+ cell numbers and increased cell migration in transwell migration assays. The CD34+ cells expanded with hWJSCs had significantly lower mitochondrial mass, mitochondrial membrane potential, and oxidative stress. Green Mitotracker-tagged mitochondria from CD34+ cells were observed lying within red CellTracker-tagged hWJSCs under confocal microscopy indicating mitochondrial transfer via tunneling nanotubes. CD34+ cells expanded with hWJSCs and hWJSC-CM showed significantly reduced oxidative phosphorylation (ATP6VIH and NDUFA10) and increased glycolytic (HIF-1a and HK-1) pathway-related gene expression. CD34+ cells expanded with hWJSCs for 7 days showed significant greater CD45+ cell chimerism in the bone marrow of primary and secondary irradiated mice when transplanted intravenously.

Conclusions: In this report, we confirmed that allogeneic hWJSCs provide an attractive platform for the ex vivo expansion of high fold numbers of UCB CD34+ cells while keeping them primitive. Allogeneic hWJSCs are readily available in abundance from discarded UCs, can be easily frozen in cord blood banks, thawed, and then used as a platform for UCB-HSC expansion if numbers are inadequate.

Citing Articles

The Evaluation of Mass/DNA Copy Number of Mitochondria in Umbilical Cord Blood-derived Hematopoietic Stem Cells Cocultured with MSCs.

Fateh K, Mansoori F, Atashi A Indian J Hematol Blood Transfus. 2024; 40(4):638-646.

PMID: 39469179 PMC: 11512953. DOI: 10.1007/s12288-024-01774-2.

L-carnitine in a certain concentration increases expression of cell surface marker CD34 and apoptosis in the rat bone marrow CD34 hematopoietic stem cells.

Fathi E, Kholosi Pashutan M, Farahzadi R, Nozad Charoudeh H Iran J Vet Res. 2022; 22(4):264-271.

PMID: 35126533 PMC: 8806168. DOI: 10.22099/ijvr.2021.39045.5677.

Wharton's jelly-derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation.

Pochon C, Notarantonio A, Laroye C, Reppel L, Bensoussan D, Bertrand A J Cell Mol Med. 2022; 26(5):1339-1350.

PMID: 35088933 PMC: 8899189. DOI: 10.1111/jcmm.17105.

Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34-enriched cells.

Bucar S, Branco A, Mata M, Milhano J, Caramalho I, Cabral J Stem Cell Res Ther. 2021; 12(1):399.

PMID: 34256848 PMC: 8278708. DOI: 10.1186/s13287-021-02474-8.

Biological Characteristics of Umbilical Cord Mesenchymal Stem Cells and Its Therapeutic Potential for Hematological Disorders.

Shang Y, Guan H, Zhou F Front Cell Dev Biol. 2021; 9:570179.

PMID: 34012958 PMC: 8126649. DOI: 10.3389/fcell.2021.570179.

References

Papa L, Djedaini M, Hoffman R . Mitochondrial Role in Stemness and Differentiation of Hematopoietic Stem Cells. Stem Cells Int. 2019; 2019:4067162. PMC: 6381553. DOI: 10.1155/2019/4067162. View

Bongso A, Fong C, Ng S, Ratnam S . Isolation and culture of inner cell mass cells from human blastocysts. Hum Reprod. 1994; 9(11):2110-7. DOI: 10.1093/oxfordjournals.humrep.a138401. View

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-7. DOI: 10.1080/14653240600855905. View

Kalaszczynska I, Ferdyn K . Wharton's jelly derived mesenchymal stem cells: future of regenerative medicine? Recent findings and clinical significance. Biomed Res Int. 2015; 2015:430847. PMC: 4377382. DOI: 10.1155/2015/430847. View

Barcia R, Santos J, Filipe M, Teixeira M, Martins J, Almeida J . What Makes Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Superior Immunomodulators When Compared to Bone Marrow Derived Mesenchymal Stromal Cells?. Stem Cells Int. 2015; 2015:583984. PMC: 4443932. DOI: 10.1155/2015/583984. View

Fong C, Gauthaman K, Cheyyatraivendran S, Lin H, Biswas A, Bongso A . Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo. J Cell Biochem. 2011; 113(2):658-68. DOI: 10.1002/jcb.23395. View

Jing D, Fonseca A, Alakel N, Fierro F, Muller K, Bornhauser M . Hematopoietic stem cells in co-culture with mesenchymal stromal cells--modeling the niche compartments in vitro. Haematologica. 2010; 95(4):542-50. PMC: 2857183. DOI: 10.3324/haematol.2009.010736. View

Wang T, Wen S, Yang K, Yang S, Yang Y, Chang C . Reasons for exclusion of 6820 umbilical cord blood donations in a public cord blood bank. Transfusion. 2013; 54(1):231-7. DOI: 10.1111/trf.12269. View

Li D, Chiu G, Lipe B, Hopkins R, Lillis J, Ashton J . Decellularized Wharton jelly matrix: a biomimetic scaffold for ex vivo hematopoietic stem cell culture. Blood Adv. 2019; 3(7):1011-1026. PMC: 6457237. DOI: 10.1182/bloodadvances.2018019315. View

10.

Sanchez V, Villalba N, Fiore L, Luzzani C, Miriuka S, Boveris A . Characterization of Tunneling Nanotubes in Wharton's jelly Mesenchymal Stem Cells. An Intercellular Exchange of Components between Neighboring Cells. Stem Cell Rev Rep. 2017; 13(4):491-498. DOI: 10.1007/s12015-017-9730-8. View

11.

Nishioka K, Fujimori Y, Hashimoto-Tamaoki T, Kai S, Qiu H, Kobayashi N . Immortalization of bone marrow-derived human mesenchymal stem cells by removable simian virus 40T antigen gene: analysis of the ability to support expansion of cord blood hematopoietic progenitor cells. Int J Oncol. 2003; 23(4):925-32. View

12.

Peled T, Shoham H, Aschengrau D, Yackoubov D, Frei G, Rosenheimer G N . Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment. Exp Hematol. 2011; 40(4):342-55.e1. DOI: 10.1016/j.exphem.2011.12.005. View

13.

Filippi M, Ghaffari S . Mitochondria in the maintenance of hematopoietic stem cells: new perspectives and opportunities. Blood. 2019; 133(18):1943-1952. PMC: 6497515. DOI: 10.1182/blood-2018-10-808873. View

14.

Jo D, Rafii S, Hamada T, Moore M . Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. J Clin Invest. 2000; 105(1):101-11. PMC: 382585. DOI: 10.1172/JCI7954. View

15.

Angelucci S, Marchisio M, Di Giuseppe F, Pierdomenico L, Sulpizio M, Eleuterio E . Proteome analysis of human Wharton's jelly cells during in vitro expansion. Proteome Sci. 2010; 8:18. PMC: 2867805. DOI: 10.1186/1477-5956-8-18. View

16.

Jang Y, Sharkis S . A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood. 2007; 110(8):3056-63. PMC: 2018677. DOI: 10.1182/blood-2007-05-087759. View

17.

Corre I, Pineau D, Hermouet S . Interleukin-8: an autocrine/paracrine growth factor for human hematopoietic progenitors acting in synergy with colony stimulating factor-1 to promote monocyte-macrophage growth and differentiation. Exp Hematol. 1999; 27(1):28-36. DOI: 10.1016/s0301-472x(98)00032-0. View

18.

Bongso A, Fong C . The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord. Stem Cell Rev Rep. 2012; 9(2):226-40. DOI: 10.1007/s12015-012-9418-z. View

19.

Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V . Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391):1145-7. DOI: 10.1126/science.282.5391.1145. View

20.

Rajan T, Gugliandolo A, Bramanti P, Mazzon E . Tunneling Nanotubes-Mediated Protection of Mesenchymal Stem Cells: An Update from Preclinical Studies. Int J Mol Sci. 2020; 21(10). PMC: 7278958. DOI: 10.3390/ijms21103481. View